RecruitingNCT03748069

Influenza Associated Aspergillosis In-depth Investigation

Unraveling the Pathogenesis of Influenza-associated Aspergillosis: a Single-center, Prospective Cohort Pilot Study


Sponsor

Universitaire Ziekenhuizen KU Leuven

Enrollment

45 participants

Start Date

Jan 18, 2019

Study Type

OBSERVATIONAL

Conditions

Summary

This trial is aimed to study the immunological and pathological characteristics of influenza versus non-influenza severe community-acquired pneumonia patients in ICU.


Eligibility

Min Age: 18 Years

Inclusion Criteria2

  • All patients older than 18 years, admitted to ICU with respiratory distress with microbiologically confirmed diagnosis of influenza (for inclusion in the influenza group)
  • All patients older than 18 years, admitted to ICU for respiratory distress due to community- acquired pneumonia , with a microbiologically confirmed absence of influenza (for inclusion in the control group)

Exclusion Criteria3

  • Age \< 18 years old
  • Pregnant women
  • No informed consent

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Universitaire Ziekenhuizen Leuven

Leuven, Belgium

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03748069


Related Trials